|
BioSignia believes the ability to quantify a unique
individual’s future health trajectory with a high level of
precision will become increasingly critical to
institutional, medical and personal decision-making. We
currently offer two market-ready applications.
Know Your Number®
(KYN) predicts the probable onset of serious medical
problems – such as stroke, coronary disease and cancer –
and offers concrete recommendations for preventive care.
KYN’s all-inclusive, user-friendly reports can be used for
a wide variety of purposes, from designing health
insurance plans and workforce wellness programs to taking
control of one’s personal life. Whatever the setting, KYN
provides a clear roadmap for achieving better health
outcomes.
Mortality
Assessment Technology (MAT) predicts mortality risk
for companies in the life insurance industry, including
direct writing, reinsurance and life settlements. Using
the computational power of Synthesis Analysis™, MAT
evaluates the combined impact a complex interplay of
medical and lifestyle factors is likely to have on an
applicant’s life expectancy. Unlike conventional
underwriting techniques, risk assessment is both holistic
and unique to each person. This higher level of
granularity results in significantly greater precision,
allowing insurers to more accurately categorize applicants
as standard, preferred or super-preferred.
|
